BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 35208545)

  • 21. The role of diffusion-weighted MRI and contrast-enhanced MRI for differentiation between solid renal masses and renal cell carcinoma subtypes.
    Serter A; Onur MR; Coban G; Yildiz P; Armagan A; Kocakoc E
    Abdom Radiol (NY); 2021 Mar; 46(3):1041-1052. PubMed ID: 32930832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Small renal masses (≤ 4 cm): differentiation of oncocytoma from renal clear cell carcinoma using ratio of lesion to cortex attenuation and aorta-lesion attenuation difference (ALAD) on contrast-enhanced CT.
    Gentili F; Bronico I; Maestroni U; Ziglioli F; Silini EM; Buti S; de Filippo M
    Radiol Med; 2020 Dec; 125(12):1280-1287. PubMed ID: 32385827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reliability and Management Outcomes Following a Percutaneous Biopsy Diagnosis of Oncocytoma: A 15-year Retrospective Analysis.
    Chai JL; Alencar RO; Hirsch MS; Bhagavatula S; Bay CP; Siegmund S; Chang SL; Silverman SG
    Radiology; 2023 Apr; 307(2):e221156. PubMed ID: 36692400
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiphasic enhancement patterns of small renal masses (≤4 cm) on preoperative computed tomography: utility for distinguishing subtypes of renal cell carcinoma, angiomyolipoma, and oncocytoma.
    Pierorazio PM; Hyams ES; Tsai S; Feng Z; Trock BJ; Mullins JK; Johnson PT; Fishman EK; Allaf ME
    Urology; 2013 Jun; 81(6):1265-71. PubMed ID: 23601445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MR texture analysis in the differentiation of renal oncocytoma with localized renal cell carcinoma subtypes.
    Wang Y; Zhang X; Wang S; Chen Y
    Br J Radiol; 2023 Aug; 96(1148):20221009. PubMed ID: 37129341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment differentiation of renal cell carcinoma subtypes by CT: the influence of different tumor enhancement measurement approaches.
    Zokalj I; Marotti M; Kolarić B
    Int Urol Nephrol; 2014 Jun; 46(6):1089-100. PubMed ID: 24381132
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Using Aorta-Lesion-Attenuation Difference on Preoperative Contrast-enhanced Computed Tomography Scan to Differentiate Between Malignant and Benign Renal Tumors.
    Grajo JR; Terry RS; Ruoss J; Noennig BJ; Pavlinec JG; Bozorgmehri S; Crispen PL; Su LM
    Urology; 2019 Mar; 125():123-130. PubMed ID: 30552939
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small renal oncocytomas: is segmental enhancement inversion a characteristic finding at biphasic MDCT?
    O'Malley ME; Tran P; Hanbidge A; Rogalla P
    AJR Am J Roentgenol; 2012 Dec; 199(6):1312-5. PubMed ID: 23169723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of MR texture analysis in histological subtyping and grading of renal cell carcinoma: a preliminary study.
    Goyal A; Razik A; Kandasamy D; Seth A; Das P; Ganeshan B; Sharma R
    Abdom Radiol (NY); 2019 Oct; 44(10):3336-3349. PubMed ID: 31300850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of renal cell carcinoma, oncocytoma, and lipid-poor angiomyolipoma by unenhanced, nephrographic, and delayed phase contrast-enhanced computed tomography.
    Ishigami K; Pakalniskis MG; Leite LV; Lee DK; Holanda DG; Rajput M
    Clin Imaging; 2015; 39(1):76-84. PubMed ID: 25457535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI features of renal oncocytoma and chromophobe renal cell carcinoma.
    Rosenkrantz AB; Hindman N; Fitzgerald EF; Niver BE; Melamed J; Babb JS
    AJR Am J Roentgenol; 2010 Dec; 195(6):W421-7. PubMed ID: 21098174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Four-phase computed tomography helps differentiation of renal oncocytoma with central hypodense areas from clear cell renal cell carcinoma.
    Qu JY; Jiang H; Song XH; Wu JK; Ma H
    Diagn Interv Radiol; 2023 Mar; 29(2):205-211. PubMed ID: 36960636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Voxel-based whole-lesion enhancement parameters: a study of its clinical value in differentiating clear cell renal cell carcinoma from renal oncocytoma.
    Chen F; Gulati M; Hwang D; Cen S; Yap F; Ugwueze C; Varghese B; Desai M; Aron M; Gill I; Duddalwar V
    Abdom Radiol (NY); 2017 Feb; 42(2):552-560. PubMed ID: 27595574
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are growth patterns on MRI in small (< 4 cm) solid renal masses useful for predicting benign histology?
    Lim RS; McInnes MDF; Siddaiah M; Flood TA; Lavallee LT; Schieda N
    Eur Radiol; 2018 Aug; 28(8):3115-3124. PubMed ID: 29492598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffusion-weighted imaging using 3.0 T MRI as a possible biomarker of renal tumors.
    Mirka H; Korcakova E; Kastner J; Hora M; Hes O; Hosek P; Ferda J
    Anticancer Res; 2015 Apr; 35(4):2351-7. PubMed ID: 25862900
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of computed tomography findings between renal oncocytomas and chromophobe renal cell carcinomas.
    Choi JH; Kim JW; Lee JY; Han WK; Rha KH; Choi YD; Hong SJ; Yoon YE
    Korean J Urol; 2015 Oct; 56(10):695-702. PubMed ID: 26495070
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High signal renal tumors on DWI: the diagnostic value of morphological characteristics.
    Zhang H; Pan J; Shen Y; Bai X; Wang Y; Wang H; Ye H
    Abdom Radiol (NY); 2019 Jan; 44(1):239-246. PubMed ID: 30141057
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative computer-aided diagnostic algorithm for automated detection of peak lesion attenuation in differentiating clear cell from papillary and chromophobe renal cell carcinoma, oncocytoma, and fat-poor angiomyolipoma on multiphasic multidetector computed tomography.
    Coy H; Young JR; Douek ML; Brown MS; Sayre J; Raman SS
    Abdom Radiol (NY); 2017 Jul; 42(7):1919-1928. PubMed ID: 28280876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Renal cell carcinoma: applicability of the apparent coefficient of the diffusion-weighted estimated by MRI for improving their differential diagnosis, histologic subtyping, and differentiation grade.
    Mytsyk Y; Dutka I; Borys Y; Komnatska I; Shatynska-Mytsyk I; Farooqi AA; Gazdikova K; Caprnda M; Rodrigo L; Kruzliak P
    Int Urol Nephrol; 2017 Feb; 49(2):215-224. PubMed ID: 27853915
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses.
    Lee-Felker SA; Felker ER; Tan N; Margolis DJ; Young JR; Sayre J; Raman SS
    AJR Am J Roentgenol; 2014 Nov; 203(5):W516-24. PubMed ID: 25341166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.